Skip to main content
Clinical Trials/NCT03253159
NCT03253159
Completed
Not Applicable

Added Conversational Hypnosis Reduced General Anesthesia Side Effects for Day Case Breast Surgery: A Prospective Randomized Phase III Clinical Trial (HYPNOSEIN)

Institut du Cancer de Montpellier - Val d'Aurelle1 site in 1 country150 target enrollmentSeptember 2014
ConditionsBreast Cancer

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Breast Cancer
Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Enrollment
150
Locations
1
Primary Endpoint
Assessment of pain scale
Status
Completed
Last Updated
5 years ago

Overview

Brief Summary

Evaluate the impact of the support in reducing postoperative adverse events in particular on the pain but also on anxiety, comfort, nausea, vomiting, and fatigue.

Detailed Description

Drug premedication with anxiolytics (benzodiazepine or equivalent) are usually prescribed to alleviate patient anxiety. However, alternative techniques, additional non-pharmacological, have proven effective in alleviating pain and anxiety perioperative. These techniques are retained relaxation therapy, reinsurance, breathing techniques and medical hypnosis as a technique of choice. Regarding medical hypnosis techniques, many studies have shown that performing a hypnotic technique performed perioperative could reduce the doses of anesthetics, postoperative pain, length of stay in the post room Interventional (SSPI) and a number of postoperative adverse effects. Among the various techniques of hypnosis that can be offered to patients in the perioperative, conversational hypnosis is to accompany the patient on admission to the block to realization of general anesthesia. This technique aims to suggest a pleasant environment and not anxiety. This study evaluate the impact of this support in reducing postoperative major adverse effects in particular on the pain but also on anxiety, comfort, nausea, vomiting, and fatigue.

Registry
clinicaltrials.gov
Start Date
September 2014
End Date
February 22, 2017
Last Updated
5 years ago
Study Type
Interventional
Study Design
Parallel
Sex
Female

Investigators

Sponsor
Institut du Cancer de Montpellier - Val d'Aurelle
Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Female \> 18 years
  • Patient with ASA\* score 1, 2, 3
  • Minor Unilateral breast surgery indication (tumorectomy, lumpectomy, limited axillary node dissection, minor breast reconstruction...)
  • Day case surgery (ambulatory surgery - living Day0-Day1)
  • General anesthesia required
  • Written informed consent
  • French medical benefit

Exclusion Criteria

  • Age \< 18 years
  • Patient with ASA score \> 4;
  • Body mass index \< 15 or 45kg/T;
  • Major Surgery indication : mastectomy, bilateral surgery, full axillary dissection, major breast reconstruction
  • Patient refusing hypnosis
  • Psychic or mental Disorders
  • Chronic pain
  • Opiate therapeutic \> 3 months
  • Not ability to speak and read French language
  • Deaf and dumb patient

Outcomes

Primary Outcomes

Assessment of pain scale

Time Frame: through study completion, an average of 5 year

Pain intensity assessment

Secondary Outcomes

  • Reduction of the pain using Visual Analogic Scale(through study completion, an average of 5 year)

Study Sites (1)

Loading locations...

Similar Trials